Case File
efta-efta00960937DOJ Data Set 9OtherFrom: Jeffrey Epstein [email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00960937
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein [email protected]>
To: "Barrett, Paul S" c
>
Subject: Re: PRIME HY RMBS #2 - S2.669mm of BOAMS 03-I B2 px talked ® 559-00 (5.8135% yield./ 3.55durn)
Date: Thu, 16 May 2013 16:03:00 +0000
ok
On Thu, May 16. 2013 at 11:32 AM, Barrett, Paul S
wrote:
Jeffrey
A few bonds coming out to the market today. Lets buy this one to replace what we sold on Tuesday. Spend around $600K.
Let me know
Paul
US Onshore CA'ents - sloe Sky WS Store Securities Low): Please co*, h Blue Ay ellgtb4Oly before saintingtoo US Onshore Went by entering the CtISIP into the web toollocated at: httpjllopvtaniectprnchostnetS080/8h,<Shape.htntl and tevIew to use flow
diem's state of residence is fisted. Oa° receive 'NO SECURffr FOUND: WOSTATES FOUND' or the securqy DOES NOT HAVE A CUSP or It not USD•denomlootect then please contact your SAS or local cconylkare officer and provide the requested security and client
Wormollon. Please note that., 'Solidity review and other pmtrade procedures must stilt& followed.
This bond Is on a 11:30am [WIC this morning. The prices listed on the email are merely price talks and are not firm offer levels. These are merely levels where we believe these bonds will trade and are tempered with where
we see value in owning them today. The bonds may trade higher/lower than the price talk level listed In this email.
Please show in all bids/Inquiries before the bid time. Late bids may not be accepted.
Please call the desk with all bids/Inquiries related to this bond.
"Source: Bloomberg
ROAMS 2003.1 82 Offered
59.00
BONDOESCRIPTFON
Props/ Rxo
10CPR
12 ramp 12 II 12 CPR
14 ramp 12 16 12 CPR
Cusp
05945XYS4
1)V401R..eo
I.5 rarer 24 32 CDR
13 romp 243 romp 24175 CDR
I 5 tamp 24 3 tamp 24 1.5 CDR
2ifunsi Face.
2.669.000
Odau Seventy
45 ramp 24 35
40 rarro24 35
35
Curren. Ftxe
982953
0,46), Rale
9 Potoonl
Prone 24 e 5 Peron
9 ramp 24 6.5 Perterl
Boni Two
Primo HAWS.
°Pim Pavane.* i'» of MI)
'co
100
160
Ratings iS&P.10031,1iR160)
oca.)3
CSI
FU
No
May.2017
Conon. Ceram
3 153%
Yield a Base Casa
5.895%
IRMO &MO
Stressena
Sass Case
—
ftecovem Cast
VIAL *Base Casa
Priteipel
BON One
5.05
Jun13100443
'ROO
Spread over by
-125
5985
485
20.084
1942
Wiederem %
44.08% al
4.91
346
2.88
Curronl Croft Enron: more
233%
Val
9.34
5.05
3.55
BO* 064inquences
8.27
Prncoi1 Window
dunl3 to Jan28
-Aril3 L Dec23
Jun131~7
50• Delinquency Centraeo
0.29x
Pnncmar WrIladown
85.92%
44.59%
0.09%
Total Colas Loss
0.49%
044%
0.41%
UNOPRLYINGCOLLATERAL DESCRIPTION
Tow 1.quiasson
11.81%
10.20%
9.41%
A,10.30 Loan B81,00) (5.000,)
Loan Covnt
412
254
liSTORICAL PERFOR
klorioege Type
prime Hybrid ARMs
1 MOS
3 MOS
IMOS
wed Avg 1.1040490 Coupon
3.400%
C ))1i
14.47
12 41
1335
WO Avg FICO Score
OVA FRO Norimmicabla
CDR
0.00
103
1.15
WO Avg Olothan.toValue
52.29%
SEV
MAMA
7895
5600
HOI AA LTV
48.79%
',Rooted Ant Loon Age
115
Owner Occupod
91.13
Too I Goo Concontrabon
CA 57%
Top 2 GeoCorg9resaiion
FL a%
Top30e*Conttoreikin
GA 4%
4 verl Current (24 mill)
84.40%
IMPORTANT DISCLAIMER:
Non-agency RMBS is a temples fixed income product and is not suitable for all investors. Please note that while desk assumptions are driven by a number of colateral and macro factors, the historical perk: mane of a deal is not indicative of its
future performance. Additionally, this message is a product of sales and trading and is not a research report. Other km/ risks to consider are outlined below:
All investments are subject to poastle loss of principal
Non-Agency bonds may have limited liquidityand dents should be aware that the secondary market for mortgage-backed securities has experienced periods of illiquidity and may do so in the future. Illiqui6ty means that there may not be any
purchasers for your class of certificates.Although any class of certificates may experience aliquklity, it is more likely that classes that are lower in the capital structure and non-investment grade related may experience greater illiquirSty than more
senior, investment-grade rated dames.
-
High Yield Non-Agency bonds ate speculative non-investment grade bonds that have higher risk of default or other adverse credit events which are appropriate for high risk investors only
Non
-Agency bonds are intended for dentswith a minimum total net worth of $.50mm. Please make sure your client fulfills this requirement before soliciting this order.
EFTA00960937
This momentary is a product of lftlorgan Global Wealth Managements Taxable Fixed Income Trading Desk and not Whlosgares Research DepiltlICIIL the views expressed infix trading desk commenury may differ from those of JPIAOrypret Research DeparbIlent. Mr opinions
expressed in this trade% desk commentary are sub;ect to change without notice and Mears:an Is under no obligation to update or keep this information current.
This email is confidential and subject to important disclaimers and conditions includin, on offers for the purchase or sale of securities, accuracy and completeness of information. viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure a copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail a by c-mail to jeraaraticgeggmail.r.nm. and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00960938
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
13100443Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.